TAK-901 cas 934541-31-8
| Product name:TAK-901 | Purity:98% min |
| CAS NO:934541-31-8 | Solubility:DMSO : 2 mg/mL (3.96 mM) |
| Molecular Formula:C28H32N4O3S | Package:Package according to customer requirements |
| Molecular Weight:504.644 | Storage:Store at -20℃ |
TAK-901 is a small-molecule inhibitor of the serine-threonine kinase Aurora B with potential antineoplastic activity. Aurora B kinase inhibitor TAK-901 binds to and inhibits the activity of Aurora B, which may result in a decrease in the proliferation of tumor cells that overexpress Aurora B. Aurora B is a positive regulator of mitosis that functions in the attachment of the mitotic spindle to the centromere; the segregation of sister chromatids to each daughter cell; and the separation of daughter cells during cytokinesis. This serine/threonine kinase may be amplified and overexpressed by a variety of cancer cell types. Check for active clinical trials or closed clinical trials using this agent.
Related Products:
Vinorelbine Tartrate; Vinblastine sulfate; Vinflunine; NU7441; Volasertib; Cidofovir; Cidofovir dihydrate; Pixantrone; Pixantrone dimaleate; Fludarabine; Fludarabine Phosphate; Clofarabine; Nelarabine; Vorinostat
Get in Touch
Have questions about our products or want to discuss a custom order? Our team is ready to help you.